Kirkland & Ellis advised Vitruvian Partners on the deal. Vitruvian Partners announced the formation of Vitruvian Investment Partnership V (VIP V), which recently held its final...
Vitruvian Partners’ €7.3 Billion Vitruvian Investment Partnership V
Inflexion Partnership Capital Fund III’s Closing at £1.75 Billion Hard Cap
Kirkland & Ellis and Carey Olsen advised Inflexion on the deal. Inflexion, a leading European mid-market private equity firm, announced the closing of Inflexion Partnership Capital...
EQT Future Fund’s Closing at EUR 3 Billion
Kirkland & Ellis advised EQT on the deal. Private Equity firm, EQT announced the final close of the EQT Future Fund, which included €3 billion ( appr....
Triton Partners Creation and Closure of Triton IV Continuation Fund
Kirkland & Ellis has advised on the Triton Partners on completing the sale of a portfolio of four companies. The newly-formed vehicle,Triton IV Continuation Fund closed at...
Silverback Therapeutics’ Merger With ARS Pharmaceuticals
Cooley represented Silverback, Kirkland & Ellis advised Nextech, Inceptiv Law advised ARS on the deal. Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”) and ARS Pharmaceuticals, Inc. (“ARS”)...
Lynstone Special Situations Fund II’s $2.4 Billion Fundraising
Kirkland & Ellis represented J.P. Morgan Asset Management in the transaction. J.P. Morgan Asset Management announced the final closing of its Lynstone Special Situations Fund II,...
Inflexion Buyout Fund VI’s £2.5 Billion Formation
Kirkland & Ellis advised Inflexion on the deal. Inflexion announced the formation of Inflexion Buyout Fund VI, which recently held its final closing at its £2.5 billion...
Helios Holdings Limited’s Combination With Fairfax Africa Holdings Corporation
McCarthy Tétrault LLP acted as legal advisor to Fairfax Africa and Fairfax Financial. Alvarium acted as financial advisor and Goodmans LLP, as legal advisor to the...